Related Experiment Video
Updated: Oct 1, 2025

11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.7K
Computing microRNA-gene interaction networks in pan-cancer using miRDriver
Banabithi Bose1, Matthew Moravec2, Serdar Bozdag3
1Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA. banabithi.bose@northwestern.edu.
Scientific Reports
|March 9, 2022
Summary
This study identifies key microRNA-gene interactions in cancer by integrating multi-omics data. These findings reveal cancer-specific and common microRNA-gene signatures impacting tumor survival and progression.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Cancer driver genes and microRNAs are often located in DNA copy number aberrated regions.
- Understanding microRNA-gene interactions is crucial for cancer research.
Purpose of the Study:
- To identify signature microRNA-gene associations in frequently aberrated DNA regions across various cancer types.
- To integrate multi-omics datasets for a comprehensive analysis of microRNA-gene interactions.
Main Methods:
- Utilized a LASSO-based regression approach.
- Integrated copy number aberration, DNA methylation, gene expression, and microRNA expression data.
- Analyzed 7294 patient samples from eighteen cancer types in The Cancer Genome Atlas (TCGA).
Main Results:
- Identified several cancer-specific and common microRNA-gene interactions, validated against known interactions.
- Highlighted oncogenic and tumor suppressor microRNAs with cancer-specific and common roles.
- Demonstrated superior performance compared to five state-of-the-art methods.
- Found associations between selected microRNAs/genes and tumor survival/progression.
- Discovered subtype-specific gene signatures and enrichment in cancer-related pathways and Gene Ontology terms.
Conclusions:
- The integrated multi-omics approach effectively identifies significant microRNA-gene interactions in cancer.
- The discovered microRNA-gene signatures offer potential biomarkers for tumor survival and progression.
- Findings provide insights into cancer mechanisms and potential therapeutic targets.

